Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Type Segment
1.1.2. Application Segment
1.1.3. End Use Segment
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Primary Research
1.5. Information or Data Analysis:
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objective
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing academic & industrial interest in mRNA technology
3.2.1.2. Advantages of mRNA vaccines
3.2.1.3. Increasing funding for mRNA research
3.2.2. Market Restraint Analysis
3.2.2.1. Nonexistence of effective government regulations for mRNA-based product approvals
3.2.2.2. High cost of mRNA synthesis raw materials
3.2.3. Market Challenge Analysis
3.2.3.1. Lack of long-lasting and affordable manufacturing processes
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Type Business Analysis
4.1. Type Segment Dashboard
4.2. U.S. mRNA Synthesis Raw Materials Market Type Movement Analysis
4.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Capping Agents
4.4.1. Capping agents market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2. CleanCap Reagents
4.4.2.1. CleanCap reagents market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3. ARCA (Anti-Reverse Cap Analog)
4.4.3.1. ARCA (anti-reverse cap analog) market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Nucleotides
4.5.1. Nucleotides market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2. Modified Nucleic Acids
4.5.2.1. Modified nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.2. N1-methylpseudouridine-triphosphate
4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.4. Others
4.5.2.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3. Natural Nucleic Acids
4.5.3.1. Natural nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3.2. Adenine
4.5.3.2.1. Adenine market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3.3. Guanine
4.5.3.3.1. Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3.4. Cytosine
4.5.3.4.1. Cytosine market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3.5. Uracil
4.5.3.5.1. Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Plasmid DNA
4.6.1. Plasmid DNA market estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Enzymes
4.7.1. Enzymes market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.2. Polymerase
4.7.2.1. Polymerase market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.3. RNase Inhibitor
4.7.3.1. RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.4. DNase
4.7.4.1. DNase market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.5. Others
4.7.5.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Application Business Analysis
5.1. Application Segment Dashboard
5.2. U.S. mRNA Synthesis Raw Materials Market Application Movement Analysis
5.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Therapeutics Production
5.4.1. Therapeutics production market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Vaccine Production
5.5.1. Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Other Application
5.6.1. Other application market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. U.S. mRNA Synthesis Raw Materials Market End Use Movement Analysis
6.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Biopharmaceutical & Pharmaceutical Companies
6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. CROs & CMOs
6.5.1. CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Academic & Research Institutes
6.6.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. F. Hoffmann-La Roche Ltd.
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Jena Bioscience GmbH
7.4.2.1. Overview
7.4.2.2. Product Benchmarking
7.4.2.3. Strategic Initiatives
7.4.3. Merck KGaA
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Yeasen Biotechnology (Shanghai) Co., Ltd
7.4.4.1. Overview
7.4.4.2. Product Benchmarking
7.4.4.3. Strategic Initiatives
7.4.5. BOC Sciences
7.4.5.1. Overview
7.4.5.2. Product Benchmarking
7.4.5.3. Strategic Initiatives
7.4.6. Thermo Fisher Scientific, Inc.
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Maravai LifeSciences
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. New England Biolabs
7.4.8.1. Overview
7.4.8.2. Product Benchmarking
7.4.8.3. Strategic Initiatives
7.4.9. Creative Biogene
7.4.9.1. Overview
7.4.9.2. Product Benchmarking
7.4.9.3. Strategic Initiatives
7.4.10. HONGENE
7.4.10.1. Overview
7.4.10.2. Product Benchmarking
7.4.10.3. Strategic Initiatives
7.4.11. Evonik Industries AG
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. GENEVANT SCIENCES CORPORATION
7.4.12.1. Overview
7.4.12.2. Product Benchmarking
7.4.12.3. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
Table 4 U.S. mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
Table 5 U.S. mRNA synthesis raw materials market, by end use, 2021 - 2033 (USD Million)
Table 6 Key companies undergoing expansions.
Table 7 Key companies undergoing acquisitions.
Table 8 Key companies undergoing collaborations.
Table 9 Key companies launching new products/services.
Table 10 Key companies undertaking other strategies.
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 U.S. mRNA synthesis raw materials market: market outlook
Fig. 7 U.S. mRNA synthesis raw materials competitive insights
Fig. 8 Parent market outlook
Fig. 9 U.S. mRNA synthesis raw materials market driver impact
Fig. 10 U.S. mRNA synthesis raw materials market restraint impact: Type & services movement analysis
Fig. 11 U.S. mRNA synthesis raw materials market: Type outlook and key takeaways
Fig. 12 Capping agents market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 13 CleanCap reagents market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 14 ARCA (anti-reverse cap analog) market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 16 Nucleotides market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 17 Modified nucleic acids market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 18 N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 5-Methylcytidine triphosphate (5mCTP) market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 20 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Natural nucleic acids market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 22 Adenine market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 23 Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Cytosine market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 25 Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Plasmid DNA market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 27 Enzymes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 28 Polymerase market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 29 RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 DNase materials market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Others market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 33 U.S. mRNA synthesis raw materials market: Application movement analysis
Fig. 34 U.S. mRNA synthesis raw materials market: Application outlook and key takeaways
Fig. 35 Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Therapeutics production market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 37 Other application market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 U.S. mRNA synthesis raw materials market: End Use movement analysis
Fig. 39 U.S. mRNA synthesis raw materials market: End Use outlook and key takeaways
Fig. 40 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 CROs CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Market share of key market players - U.S. mRNA synthesis raw materials market
